Allergen Testing in Clinical Trials
Authored by Dr. Beverley Riley, Research and Development Manager, ACM Global Laboratories
Developing treatments for allergy is dependent on technology that identifies IgE and allergen-specific IgE. With the rapid improvement in this technology, trial sponsors should understand the many options available.
To view the full report, please download your copy
Clinical Insight Sign-up
Clinical Insight, a series of technical reports, is written by our team of global central lab experts on issues affecting clinical testing today. They provide detailed information concerning current methodology, specimen requirements, and reference ranges on new and specialized tests.
In Clinical Insight, our experts provide their opinions on the clinical significance of specific tests and how they can impact your clinical trial.